Clinical Trials Directory

Trials / Completed

CompletedNCT03554057

CCTA to Optimize the Diagnostic Yield of Invasive Angiography

Coronary Computed Tomographic Angiography to Optimize the Diagnostic Yield of Invasive Angiography in Lower Risk Patients

Status
Completed
Phase
Study type
Observational
Enrollment
186 (actual)
Sponsor
Hamilton Health Sciences Corporation · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study aims to reduce patient risk and costs to the healthcare system by improving the diagnostic yield of invasive coronary angiography through existing triage processes to improve risk stratification using Coronary Computed Tomographic Angiography (CCTA) as a first step in low risk patients. All low-risk patients referred for invasive coronary angiography will be potentially eligible for CCTA instead of invasive angiography as a first-line diagnostic test. All CCTAs will be read by both a level 3-trained cardiologist and a radiologist. The results of the CCTA, coupled with evidence-based management recommendations will be sent to the referring physician and an invasive angiogram will be arranged by the HIU triage, only when clearly indicated

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCoronary Computed Tomographic AngiographyAll low-risk patients referred for invasive coronary angiography will be potentially eligible to receive the intervention over a 12-month period. The intervention will include risk stratification using Coronary Computed Tomographic Angiography (CCTA) at HHS and NHS as an alternative to upfront invasive angiography. All CCTAs will be read by both a level 3-trained cardiologist and a radiologist. The results of the CCTA, coupled with evidence-based management recommendations will be sent to the referring physician and an invasive angiogram will be arranged only when indicated as per these management recommendations

Timeline

Start date
2018-07-09
Primary completion
2020-02-28
Completion
2022-03-01
First posted
2018-06-12
Last updated
2022-03-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03554057. Inclusion in this directory is not an endorsement.